--- title: Profil World - The clinical diabetes research newsletter - Mar 2023 description: "Read the latest volume of \"Profil World\". Meet us at upcoming conferences and discuss with us the next steps of your clinical development." image: https://blog.profil.com/hubfs/Header_1077x400px_520x272_About_Profil_edited.jpg --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg") # Profil World - The clinical diabetes research newsletter - Mar 2023 ![Christopher](https://blog.profil.com/hubfs/Profil_Mitarbeiter/Chris_Hexagon_154x175.png) Posted by [Christopher Haiduk](https://blog.profil.com/blog/author/christopher-haiduk) on Mar 31, 2023 6:03:00 PM ![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.") ![Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.") Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. ### On-demand seminar:  Insulin Biosimilars - More focus than ever on Glucose Clamp studies [![Profil Banner 2021_04_on-demand4-1](https://blog.profil.com/hs-fs/hubfs/Online%20Seminars/Profil%20Banner%202021_04_on-demand4-1.png?width=215&height=150&name=Profil%20Banner%202021_04_on-demand4-1.png)](https://info.profil.com/free-online-seminar-insulin-biosimilars)We record all of our free [online seminars](https://www.profil.com/knowledge-center/online-seminars), so that you have the possibility to watch them on-demand at your convenience. Watch here our on-demand online seminar titled: "Insulin Biosimilars - More focus than ever on Glucose Clamp studies". Profil's Co-Founder and Lead Scientist Dr. Tim Heise gives you valuable information regarding the development of biosimilar insulins and explains what authorities are looking for. [Watch here](https://info.profil.com/free-online-seminar-insulin-biosimilars)       ### CTR 536/2014: Where do we come from and where do we go?  [![bgm](https://blog.profil.com/hs-fs/hubfs/Pictures/bgm.jpg?width=210&name=bgm.jpg)](https://blog.profil.com/blog/ctr_ctis_part1)Although the "Clinical Trial Regulation" came into force in May 2014, it took a while until the message "Portal ready to use" was received. In January 31st the "Clinical Trials Information System" (CTIS) became the single entry point for submitting clinical trials in the EU. In this two part blog post series Dr. Grit Andersen and Tatiana Dicenzo summarize the changes and chances which come with the new system. [Read more](https://blog.profil.com/blog/ctr_ctis_part1)     ### A co-formulation of pramlintide and insulin A21G (ADO09) [![0090_RGB_215x150-1](https://blog.profil.com/hs-fs/hubfs/0090_RGB_215x150-1.jpg?width=210&height=147&name=0090_RGB_215x150-1.jpg)](https://pubmed.ncbi.nlm.nih.gov/36633505/)The co-formulation of pramlintide and insulin A21G (ADO09) requires additional injections, but can have benefits regarding postprandial glucose and short term control of mean glucose. Read our latest [publication ](https://www.profil.com/knowledge-center/publications)about recent study results of this co-formulation  compared to insulin aspart in adult patients with type 1 diabetes mellitus.  [Read more](https://pubmed.ncbi.nlm.nih.gov/36633505/)       Meet us at upcoming conferences  [![Conferences_215x150](https://blog.profil.com/hs-fs/hubfs/Conferences_215x150.jpg?width=210&height=147&name=Conferences_215x150.jpg)](https://info.profil.com/meet-profil-at-a-conference)Are you interested in knowing more about Profil? We attend all major [conferences](https://www.profil.com/organisation/conferences) focused on diabetes, so if you are planning to go to any upcoming conference, we would love to [schedule a meeting](https://info.profil.com/meet-profil-at-a-conference) and tell you more about our expertise! Upcoming events in 2022: [KoreaPharm](https://www.koreapharm.org/eng/main.asp?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-9k1ovgwFnnkDusLOMRafQQW3oNfzkDEQq10BWRsK2kGD8ww9LO44mvPAMuYV3T4ePDYhFS), April 18 - 21, 2023, Ilsanseo-gu, South Korea [Asia Bio](https://informaconnect.com/asia-bio-partnering-forum/?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-9k1ovgwFnnkDusLOMRafQQW3oNfzkDEQq10BWRsK2kGD8ww9LO44mvPAMuYV3T4ePDYhFS), April 26 - 27 2023, Singapore [OCT Europe](https://www.arena-international.com/event/octeurope/?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-9k1ovgwFnnkDusLOMRafQQW3oNfzkDEQq10BWRsK2kGD8ww9LO44mvPAMuYV3T4ePDYhFS), May 03 - 04 2023, Barcelona, Spain [                                                                      Bio International Convention](https://www.bio.org/events/bio-international-convention?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-9k1ovgwFnnkDusLOMRafQQW3oNfzkDEQq10BWRsK2kGD8ww9LO44mvPAMuYV3T4ePDYhFS), June 05 - 08 2023, Boston, MA, USA [                                                                      ADA 83rd Scientific Sessions](https://professional.diabetes.org/scientific-sessions?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-9k1ovgwFnnkDusLOMRafQQW3oNfzkDEQq10BWRsK2kGD8ww9LO44mvPAMuYV3T4ePDYhFS), June 23 - 26 2023, San Diego, CA, USA   [![Werbebanner_468x60](https://blog.profil.com/hs-fs/hubfs/Pictures/Werbebanner_468x60.jpg?width=468&height=60&name=Werbebanner_468x60.jpg)](https://bio.german-pavilion.com/en/exhibitors/97418/)   Topics: [About Profil](https://blog.profil.com/blog/topic/about-profil) [Leave a comment](https://blog.profil.com/blog/profil-world-newsletter-2023-march#comment_form) ### Subscribe to Email Updates ### Our most popular Posts ### Posts by Topic - [Clinical Trials in Diabetes (127)](https://blog.profil.com/blog/topic/clinical-trials-in-diabetes) - [About Profil (69)](https://blog.profil.com/blog/topic/about-profil) - [Clinical Trial Methods (68)](https://blog.profil.com/blog/topic/clinical-trial-methods) - [The Science behind Diabetes (64)](https://blog.profil.com/blog/topic/the-science-behind-diabetes) - [Treating Diabetes (62)](https://blog.profil.com/blog/topic/treating-diabetes) - [Diabetes Technology (41)](https://blog.profil.com/blog/topic/diabetes-technology) - [Clinical trials in Obesity (11)](https://blog.profil.com/blog/topic/clinical-trials-in-obesity) - [Events (4)](https://blog.profil.com/blog/topic/events) - [CRO selection (2)](https://blog.profil.com/blog/topic/cro-selection) - [Regulatory Affairs (2)](https://blog.profil.com/blog/topic/regulatory-affairs) [see all](https://blog.profil.com/blog/profil-world-newsletter-2023-march#) ## You might also like this post ### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)